造血干细胞移植后移植物抗宿主病的腹部与盆腔影像表现
本文总结造血干细胞移植后移植物抗宿主病(GVHD)在腹部与盆腔的影像表现。胃肠道可见肠壁增厚伴黏膜强化、肠系膜水肿和血管充盈;肝胆系统可见肝脾增大、门静脉周围水肿、胆管扩张及胆囊和胆管壁增厚。影像表现本身不特异,但结合移植史、移植时间与类型、实验室检查、粪便检查及皮肤表现,可提高放射科医生提示该诊断的信心。
要点
- 胃肠道GVHD可见肠壁增厚伴黏膜强化、肠系膜水肿及血管充盈。
- 肝胆系统GVHD可见肝脾增大、门静脉周围水肿、胆管扩张及胆囊与胆管壁增厚。
- GVHD影像表现不特异,需结合HSCT病史、移植时间与类型、实验室与粪便检查及皮肤表现综合判断。
核心结论
- GVHD是HSCT后的严重并发症,累及多器官系统,影像表现最常见于胃肠道和肝胆系统。
- GVHD的影像表现本身可能相对不特异,结合临床病史(包括HSCT的时间与类型)、实验室值、粪便检查和皮肤表现,可提高放射科医生提示该诊断的信心。
研究设计与样本
- 本文为关于HSCT后GVHD腹部与盆腔影像表现的综述,原文未报告检索范围与纳入文献数量。
关键影像表现/征象
- 胃肠道表现包括肠壁增厚伴黏膜强化、肠系膜水肿和血管充盈。
- 肝胆系统表现包括肝脾增大、门静脉周围水肿、胆管扩张以及胆囊和胆管壁增厚。
临床应用与阅片要点
- 在已知HSCT病史的情况下,即使影像表现不特异,也应考虑GVHD。
- 结合HSCT的时间与类型、实验室值、粪便检查和皮肤表现,可提高提示GVHD诊断的信心。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Graft-versus-host disease (GVHD) is a common complication of hematopoietic stem cell transplant (HSCT). GVHD predominantly affects the skin, gastrointestinal system and hepatobiliary systems. Imaging findings in the gastrointestinal tract include bowel wall thickening with mucosal enhancement, mesenteric edema, and vascular engorgement. In the hepatobiliary system, hepatosplenomegaly, periportal edema, bile duct dilatation, and gallbladder and biliary wall thickening are seen. Although the imaging findings of GVHD are nonspecific, with a known history of HSCT, GVHD should be considered.
CONCLUSION: GVHD is a serious complication of HSCT, which involves multiple organ systems, with imaging manifestations most commonly seen in the gastrointestinal tract and hepatobiliary system. Knowledge of the imaging manifestations of GVHD, which alone may be relatively nonspecific, taken in conjunction with clinical history including the timing and type of HSCT, laboratory values, stool studies, and dermatologic findings can increase radiologist confidence in suggesting this diagnosis.
引用
- Lubner MG, Menias CO, Agrons M, et al. Imaging of Abdominal and Pelvic Manifestations of Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplant. AJR Am J Roentgenol. 2017. PMID: 28463600. doi:10.2214/AJR.17.17866
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。